ElucidVivo A.3— 510(k) K221463

Substantially Equivalent

Elucid Bioimaging, Inc.

FDA 510(k) clearance K221463 for ElucidVivo A.3, Substantially Equivalent on 2022-06-17. Applicant: Elucid Bioimaging, Inc..

Clearance details

Applicant: Elucid Bioimaging, Inc.
Product code: Code LLZ
Advisory panel: Radiology
Date received: 2022-05-19
Decision date: 2022-06-17
Decision: Substantially Equivalent
Clearance type: Special
Location: Boston, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.